Home » Topics » Regulatory

Regulatory
RSS

DepoCyt earns positive phase III results

June 28, 1996

Zithromax approved by FDA for new indication

June 28, 1996

Viramune receives accelerated FDA approval

June 28, 1996

Connective Therapeutics to develop new formulation of betamethasone valerate

June 28, 1996

Anakinra claimed for pancreatitis

June 21, 1996

FDA approval of new indication for Genentech's Activase

June 21, 1996

Mitsubishi Chem.'s Novastan receives Japanese approval for new indication

June 21, 1996

Vesnarinone treatment recommendations

June 21, 1996

Astra's Pulmicort approaches FDA approval

June 21, 1996

FDA approval of novel Claritin formulation sought

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 13, 2025.
Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal
BioWorld
With a packed pipeline of drug candidates targeting multiple markers of cancer, Bayer AG signed on for a new project, this time going after the KRAS pathway with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 13, 2025.
Scemblix ticks Novartis earnings box; more ahead in CML
BioWorld
Novartis AG’s financial update included good news about Scemblix (asciminib), the first and only U.S. FDA-approved allosteric inhibitor for chronic myeloid...
NME Digest: Q2 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...